logo
Trump's chronic venous insufficiency diagnosis 'extremely common' in older adults

Trump's chronic venous insufficiency diagnosis 'extremely common' in older adults

U.S. President Donald Trump was recently diagnosed with a condition called chronic venous insufficiency (CVI).The condition can be uncomfortable or painful, although it is not considered a serious medical condition and is treatable.Medical News Today spoke to two medical experts to learn more about CVI, health complications related to it, and how to reduce risks of developing the condition.President Donald Trump has been diagnosed with chronic venous insufficiency (CVI), which leads to symptoms such as swelling, pain, and skin discoloration due to blood pooling in the legs and damaging veins.The official announcement came July 17 from White House press secretary Karoline Leavitt, who said the 79-year-old president had 'mild swelling in his lower legs,' which led to further tests and examination.'The president underwent a comprehensive examination including diagnostic vascular studies. Bilateral lower extremity intravenous doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70,' Leavitt said.Despite concerns, CVI can be treated and is quite common in older adults, affecting about 10 to 35% of adults in the United States.The White House also said there was no evidence of deep vein thrombosis, a serious life-threatening condition, and that an echocardiogram (ECG) showed his heart was functioning normally. So, what are the first signs of CVI and how can one reduce their risk? Are there any treatments for CVI? To learn more about this condition, Medical News Today spoke to two experts — Cheng-Han Chen, MD, board certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA, and Christopher Yi, MD, board certified vascular surgeon at MemorialCare Orange Coast Medical Center in Fountain Valley, CA to answer these questions and more.What are the first signs of CVI?The way Trump presented with mild swelling (edema) in his legs is often the first sign of chronic venous insufficiency (CVI). 'Chronic venous insufficiency typically first manifests as swelling in the legs and ankles/feet, particularly after sitting or standing for a long time. People also sometimes feel a 'heaviness' or aching in the legs. Some people might also notice varicose veins in the leg associated with this condition,' Chen said. People often notice discomfort or aching that worsens after long periods of standing or sitting. Other early signs can include mild skin changes, such as dryness or itchiness, and the appearance of small varicose or spider veins,' Yi said.Is CVI life threatening?Although blood pooling in legs can sound worrying, this condition is common in older adults, and with timely treatment, risks of complications can be greatly reduced.'This condition is extremely common in the population, with some estimates that up to 40% of Americans are affected,' Chen said. 'For most people, chronic venous insufficiency will be benign, but it can become more serious if left untreated. Some complications of untreated chronic venous insufficiency include ulcers, pain, and skin changes,' he continued.'It is generally not life-threatening but can progress if left untreated, leading to complications such as severe swelling, skin changes, venous ulcers, and an increased risk of deep vein thrombosis (DVT),' Yi said.What increases the risk of CVI?A variety of factors, such as not engaging in enough physical activity, smoking, and having obesity or overweight can increase a person's risk of developing CVI.'Risk factors include advanced age, obesity, a sedentary lifestyle, prolonged standing or sitting, family history of venous disease, prior leg injuries or blood clots, pregnancy, and smoking. Men can develop CVI, but it is slightly more common in women,' Yi said.How is CVI treated?Although Trump's medical records show that he takes aspirin, a blood thinner, this is likely for cardiac prevention, and not CVI, experts say.'Aspirin is not a primary treatment for chronic venous insufficiency. It is sometimes prescribed for other cardiovascular reasons, such as reducing the risk of heart attack or stroke, but it does not significantly improve venous circulation or relieve CVI symptoms,' Yi explained.'Aspirin is sometimes used to help venous ulcers heal, but is not considered a first-line treatment for chronic venous insufficiency,' Chen said.'Compression therapy and lifestyle measures are far more effective,' Yi added.Lifestyle changes can lessen symptomsYi said that wearing compression stockings was one of the most effective strategies for treating CVI as it helps blood flow back toward the heart. 'Lifestyle changes are also important, including regular physical activity, maintaining a healthy weight, and elevating the legs above heart level for short periods throughout the day. It's helpful to avoid prolonged sitting or standing, and when possible, take breaks to walk or flex the ankles to encourage blood flow. Good skin care is essential to prevent irritation, dryness, or breakdown that can occur with poor circulation,' Yi said.When lifestyle changes may not be enough to improve symptoms, doctors may also prescribe some medical procedures.'These can include medications, such as venoactive agents, which can help reduce symptoms. For more advanced cases, minimally invasive procedures like endovenous laser or radiofrequency ablation, sclerotherapy, or even surgical vein stripping may be performed to close or remove damaged veins and restore better circulation,' said Yi.'We typically recommend lifestyle modifications such as elevating the legs, wearing compression stockings, increasing physical activity, and losing weight. For more serious cases, minimally invasive procedures such as ablation and sclerotherapy can be helpful in alleviating symptoms.'— Cheng-Han Chen, MD
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Roche to investigate whether new drug can delay or prevent Alzheimer's disease
Roche to investigate whether new drug can delay or prevent Alzheimer's disease

Reuters

time38 minutes ago

  • Reuters

Roche to investigate whether new drug can delay or prevent Alzheimer's disease

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

Reuters

time2 hours ago

  • Reuters

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.

Hospital begs for help identifying woman who has been in their care for past 100 days
Hospital begs for help identifying woman who has been in their care for past 100 days

Daily Mail​

time3 hours ago

  • Daily Mail​

Hospital begs for help identifying woman who has been in their care for past 100 days

A Manhattan hospital is begging for the public's help in identifying a woman who was admitted more than 100 days ago. On April 12 around 4:45am, a woman believed to be in her late-fifties was sitting at a Harlem bus stop when a bystander dialed 911. It is unclear why an ambulance was called, but she was taken to Mount Sinai in Morningside Heights - where she has remained ever since. Employees have described the mysterious patient, who may go by the name Pam, as shy. In a photo shared by the hospital, she was seen covering her face with a towel. But these surface-level details are all officials have gathered about Pam during her three months at the hospital, and now hospital workers are trying to fill in the gaps. The hospital is asking anyone with information on who she might be to come forward, NBC reported. Pam is 5'8" tall and weighs 170 pounds. Hospital workers believe she was often in the Harlem area and generally wore black and covered her face. She speaks English and has greying hair. The Daily Mail has reached out to Mount Sinai for comment. Anyone with information regarding Pam's identity should contact the hospital's associate director of social work Kelly LaTerra at 646-901-9309. Last month, a California man was found unconscious and was rushed to St. Mary Medical Center in Long Beach. He was believed to be in his mid-forties, but just as in Pam's case, little else was known about the patient. A chilling photo released by Dignity Health showed the man lying in a hospital bed, hooked up to a ventilator. In October 2024, another California hospital took a similar approach to Mount Sinai in hopes of identifying a seriously ill patient. Staff at the Riverside Community Hospital had done everything they could think of, but could not determine the name of a man who came through the facility's doors a month earlier. They refused to say what was wrong with him or why he was attached to a ventilator, but released a photograph in the hopes that someone can put a name to the face. Identifying John or Jane Doe patients is no easy task, as doctors and other hospital staff members must work to find out who they are without violating their rights. The New York Department of Health has protocols in place specifically for missing children, college students and vulnerable adults. These standards were set in 2018 after 'several instances of a missing adult with Alzheimer's disease who was admitted to a hospital as an unidentified patient and police and family members were unable to locate the individual.' However, the process is not as cut and dry when it is the hospital asking for the public's help instead of the other way around. While hospitals have been known to share images of unknown patients when all else fails, they are not allowed to reveal much about their circumstances.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store